You've heard of the Shark Tank ...
Welcome to the

Thanks so much for the opportunity and hospitality. It was a lot of fun and we were very happy that we generated interest and contacts. Please let me know if there is anything I can do for you in the future. Your work with the 128 Innovation Capital Group really is a great help and support to the entrepreneurial community.

Bill Leak, Whipshotz
Piranha Pond Presenter, June 2013

The Piranaha Pond event at SNEEF has been one of our most successful events to date. It brought a diversity of startups, with founders who were able to get expert advice from a panel of seasoned investors and make connections. Likewise, the audience had the opportunity to learn about these startups and hear from the experts about how they can grow.

Diana Jennings, Chair, Board of Advisors
Southern New England Entrepreneurs Network (SNEEF)

The next

Tuesday, July 14th, 2015 from 6:00 - 9:00 PM at

TechSandBox, 105B South Street Hopkinton, MA 01748

Register to Attend This Event

Applications to present at this event accepted 5/27/2015 - thru 7/3/2015 at 5 PM

Download Entrepreneur Guidelines

Apply to Present

What is the Piranha Pond? It is a “pitch party” where a select group of entrepreneurs has up to 5 minutes to convince a panel of investors to meet with them to further discuss their ventures. Using a format similar to the popular television show Shark Tank, our investors provide feedback to the entrepreneurs about their presentations and companies, and information to all about why they decide to be “In” or “Out.” If they are “In” they will meet with the Entrepreneur at a later time to discuss their company. If they are “Out” there is no interest at this time. Again, the investor lets us know why s/he will not move forward with the presenter.

For this event, we seek companies beyond the idea stage. The ideal company will have raised funds from friends, family, and/or grants such as SBIR’s. If the company’s product is a software or SAAS product, it should be in beta testing or later.



Investor Panelists

Dr. Nitigna Desai

Dr. Nitigna Desai  is an "impact investor" within the TiE Boston Angel community. Dr. Desai - a board-certified psychiatrist - focuses on value propositions in the life science sector that provide chronic care to improve long term patient outcomes and is intensely focused on value-based medicine.  She is an active investor who has participated in several TiE Boston Angel portfolio companies - diversified within the life science space including cardiovascular device space, cancer diagnostic space and digital health space.

Dr. Desai is an Assistant Professor of Psychiatry at UMass Medical School and Boston University School of Medicine and currently works at VA Medical Center in Bedford, MA

Marina Hatsopoulos

Marina Hatsopoulos is an entrepreneur, director and angel investor.  She is Chairperson of the Board and investor in Levitronix Technologies, the worldwide leader in magnetically levitated bearingless motor technology. She is a Director of Cynosure Inc., a $250 million leader in the laser aesthetics market. She is also a Director and investor in Dear Kate, which sells performance apparel using advanced materials. She is on the Advisory Board of the Nantucket [technology] Conference, the EGG acceleration program in Greece, and MIT Enterprise Forum Greece. She holds a B.A. from Brown University and an M.S. from the Massachusetts Institute of Technology.


Maia Heymann

Maia Heymann is Senior Managing Director of CommonAngels Ventures, a $27M early-stage venture fund comprised of investors who are leaders in the tech community.

Previously, Maia was a Partner at BancBoston Ventures where she opened and ran Palo Alto office; developed strategy, hired team, and built investment portfolio; eventually headed BancBoston Ventures within Bank of America's Private Equity Group; managed $330M portfolio and team; returned $675M+ in 4 years.

Personal investor since 2006; named a top angel investor in New England by Xconomy; formed DeVere Management Group to house the investments.

Tasnia Huque

Tasnia Huque is on the investment team at Cue Ball and is responsible for prospecting, evaluating and executing investment opportunities. She also assists with designated portfolio companies which include Banyan Water, Epic Burger, Lex Machina, ShapeUp, and Redline.

Cue Ball Investment Criteria:

· Typical check size of $3M - $7M | Series A our sweet spot, but also opportunistically do seed, although not core

· Industry focus on enterprise internet, B2B information services, Fin Tech, Digital Media and opportunistically tech enabled retail

· Focus on “quality of revenue” – revenue recurrence rates, diversity of revenue and profitability

· Main value add is helping companies scale to the next level and also wish to be a value add partner at all aspects of the business

Kathy Rocha

Kathy Rocha is founder of KFR & Associates, a consulting company that works with technology and small business clients to improve their business with a focus on strategic planning, revenue growth and bottom line contribution. In addition, Kathy is currently managing director of UConn's Entrepreneurship and Innovation Consortium which provides an integrated view of university initiatives involving entrepreneurship and new venture development. She is a Managing Director with Golden Seeds, a private equity angel investment group that specializes in investing in companies led by women entrepreneurs.

Prior to KFR and Golden Seeds, Kathy spent her career as a leader in business strategy, operations, and general management. Her positions included vice president of business strategy and operations for Cisco Systems Network Management Technology Group and general manager of several profitable networking product divisions at 3Com Corp.






































Please note: There is a $50 application fee required in order to be considered. A selection committee will choose the top 8 applicants to present. The successful applicants will be deemed to have companies most likely to interest the investment panel. In the past, the successful companies have been beyond the idea stage, with a finished product and/or revenue or significant progress toward commercialization if a pharma, equipment or medical device company.


Please note: There is a $50 application fee required in order to be considered. A selection committee will choose the top 8 applicants to present. The successful applicants will be deemed to have companies most likely to interest the investment panel. In the past, the successful companies have been beyond the idea stage, with a finished product and/or revenue or significant progress toward commercialization if a pharma, equipment or medical device company.

This is a public event.

Attendance fees for this meeting:

General admission - $35

128ICG Members - $25